CKDXY News and Press, Opthea Ltd ADR

A clinical stage biopharmaceutical company developing a novel therapy to treat highly prevalent and progressive retinal diseases, Opthea Limited (CKDXY) has filed for IPO of American Depositary Shares (ADSs).The company intends to list the ADSs on the Nasdaq Global Market, under the tick...

Graybug Vision (GRAY) has priced its upsized initial public offering of 5.628M (from 4.79M) at $16, at the midpoint of the expected range of $15-$17.Underwriters' over-allotment is an additional 843,750 shares.Trading kicks-off today on the Nasdaq Global Market.Offering is expected ...

Graybug Vision (GRAY) has filed a preliminary prospectus for an $86M IPO. More news on: Roche Holding AG, REGENXBIO Inc., Opthea Limited, Healthcare stocks news, IPO News, , Read more ...

AbbVie (NYSE: ABBV ) unit Allergan has received a Complete Response Letter (CRL) from the FDA regarding its marketing application seeking approval of DARPin drug abicipar pegol for the treatment of neovascular age-related macular degeneration (wet AMD). More news on: AbbVie Inc., Molecul...

Opthea Limited ( OTCPK:CKDXY ) completes enrollment in a 117-subject Phase 2a clinical trial evaluating the combination of OPT-302 and Regeneron Pharmaceuticals' Eylea (aflibercept) in diabetic macular edema patients. More news on: Opthea Limited, Healthcare stocks news, Read more ...

Opthea Limited ( OTCPK:CKDXY ) announces  additional data from a Phase 2b clinical trial evaluating the combination of OPT-302 and Roche's ( OTCQX:RHHBY ) Lucentis (ranibizumab) compared to Lucentis alone in wet AMD patients. The results were presented at the European Society of Reti...

Opthea Limited ( OTCPK:CKDXY ) completes recruitment into ongoing Phase 2b trial of OPT-302 for wet age-related macular degeneration (AMD). More news on: Opthea Limited ADR, Healthcare stocks news, Read more ...

Opthea Limited ( OTCPK:CKDXY ) has commenced a Phase 1b/2a trial evaluating the safety and efficacy of OPT-302 in patients with center-involved diabetic macular edema (DME). More news on: Opthea Limited ADR, Healthcare stocks news, Read more ...